Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Intelligence Awards launched

August 23, 2006
Sales and Marketing BHBIA

The first ever awards for business intelligence and market research in the UK pharmaceutical industry have been launched to recognise …

News

Time to get back to our scientific basics

August 23, 2006
Research and Development biotech, drug safety, industry reputation

Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …

Feature

New broom Kindler sweeps away Pfizer bureaucracy

August 21, 2006
Research and Development, Sales and Marketing

Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …

News

Pfizer switches agencies in time for Sutent’s UK launch

August 18, 2006
Medical Communications Reynolds-Mackenzie, Sutent

 Pfizer has enlisted PR agency Reynolds-Mackenzie to support the UK launch and subsequent development of its potential blockbuster kidney cancer …

News

Head-to-head: Nice and the SMC

August 16, 2006
Research and Development, Sales and Marketing NICE, SMC, healthcare

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …

Feature

NICE gives breast cancer drugs the green light

August 15, 2006
Sales and Marketing

Aromatase inhibitors are to become more widely available for post-menopausal women with early breast cancer.As expected, NICE's final appraisal determination …

News

Vernalis takes diabetes pain drug into phase II

August 15, 2006
Research and Development Vernalis

UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …

News

Huge regional variations in NHS spending revealed

August 11, 2006

A new report has revealed large differences in how NHS money is spent across England, with some PCTs spending much …

News

NHS research could face

August 11, 2006
Research and Development

The British Medical Association is questioning the government over a possible 300 million pound drop in funding available for medical …

News

Empowering patients will cut medication errors, says watchdog

August 11, 2006
patients

An NHS watchdog has urged renewed efforts to cut the number of drug errors by improving prescribing and dispensing in …

News

Generic version of Plavix launched in US

August 10, 2006
Sales and Marketing

A generic company has launched a version of blood-thinning blockbuster product Plavix in the US, threatening the $3.3 billion sales …

News

GSK delivers strong quarterly performance

August 9, 2006
Sales and Marketing

GlaxoSmithKline's pharmaceutical sales rose by 10% in this year's second quarter earning the company a total of five billion pounds.Sales …

News

Lilly’s new products drive up sales

August 8, 2006
Sales and Marketing

Accelerated sales of predicted blockbuster depression treatment Cymbalta have helped boost Lilly sales for the second quarter of 2006.The drug …

News

Identifying and nurturing talent in your salesforce

August 7, 2006
Sales and Marketing Schering-Plough, UK, sales, strategy

The aim of every company, pharma or otherwise, is to boost sales and take a greater market share. However, despite …

Feature

Takeda selects London for new European business

August 4, 2006
Sales and Marketing

Japanese pharmaceutical company Takeda has chosen London as the site of its new four million pound European sales and marketing …

News

McKinnell makes early exit from Pfizer

August 3, 2006
Sales and Marketing Pfizer

Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …

Feature

Pfizer’s Sutent receives conditional EMEA approval

August 3, 2006
Sales and Marketing

 Pfizer's new kidney cancer drug Sutent is rapidly catching up with its recently approved rival, Bayer's Nexavar.Sutent (sunitinib) has been …

News

Crestor leads AZ European sales growth

August 3, 2006
Sales and Marketing

Crestor was AstraZeneca's most rapidly expanding product in terms of European sales in the second quarter of this year.  Sales …

News

Pfizer’s smoking-cessation drug a step closer to European approval

August 3, 2006
Sales and Marketing

Pfizer's potential blockbuster smoking cessation drug Champix has been recommended for European approval by a key EMEA committee.The first-in-class treatment …

News

Study boost for AstraZeneca’s Nexium

August 1, 2006
Sales and Marketing

AstraZeneca's blockbuster gastro-oesophageal reflux disease treatment Nexium has come out ahead of Wyeth's Zoton in a new study, which showed …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025